Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 114(3): 435-442, 2017 01 17.
Artículo en Inglés | MEDLINE | ID: mdl-28096504

RESUMEN

China's 13th Five-Year Plan, launched in March 2016, provides a sound policy platform for the protection of marine ecosystems and the restoration of capture fisheries within China's exclusive economic zone. What distinguishes China among many other countries striving for marine fisheries reform is its size-accounting for almost one-fifth of global catch volume-and the unique cultural context of its economic and resource management. In this paper, we trace the history of Chinese government priorities, policies, and outcomes related to marine fisheries since the 1978 Economic Reform, and examine how the current leadership's agenda for "ecological civilization" could successfully transform marine resource management in the coming years. We show how China, like many other countries, has experienced a decline in the average trophic level of its capture fisheries during the past few decades, and how its policy design, implementation, and enforcement have influenced the status of its wild fish stocks. To reverse the trend in declining fish stocks, the government is introducing a series of new programs for sustainable fisheries and aquaculture, with greater traceability and accountability in marine resource management and area controls on coastal development. As impressive as these new plans are on paper, we conclude that serious institutional reforms will be needed to achieve a true paradigm shift in marine fisheries management in China. In particular, we recommend new institutions for science-based fisheries management, secure fishing access, policy consistency across provinces, educational programs for fisheries managers, and increasing public access to scientific data.


Asunto(s)
Explotaciones Pesqueras , Animales , China , Conservación de los Recursos Naturales/economía , Conservación de los Recursos Naturales/legislación & jurisprudencia , Ecosistema , Explotaciones Pesqueras/economía , Explotaciones Pesqueras/historia , Explotaciones Pesqueras/legislación & jurisprudencia , Peces , Historia del Siglo XX , Historia del Siglo XXI , Política Pública
2.
Mol Cancer ; 14: 177, 2015 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-26438046

RESUMEN

BACKGROUND: Apoptosis-stimulating of p53 protein 2 (ASPP2) is one of the ASPP family members and it has been reported to be associated with human cancer. However, the role of it in pancreatic cancer is still not clear. METHODS: We analyzed the expression level of ASPP2 in cancer tissue samples with RT-qPCR, Western Blotting assay and immunohistochemistry staining. We studied the biological function of ASPP2 and its mechanism with gene overexpression and gene silencing technologies. We determined the sensitivity of pancreatic cells with differential ASPP2 level to gemcitabine and whether autophagy inhibition affected the gemcitabine resistance, both in vitro and in vivo. RESULTS: Expression of ASPP2 was downregulated in cancerous tissues in comparison with para-cancerous tissues. ASPP2 expression was linked to clinical outcomes in patients and down-regulation of ASPP2 increased cell proliferation, autophagic flux, the activity of AMP Kinase of pancreatic cancer cells and vice versa. Knockdown of ASPP2 results in increased resistance to gemcitabine, which was attributed to the enhanced autophagy. CONCLUSIONS: ASSP2 expression is lower in cancerous tissues and decreased ASPP2 lead to higher cancer cells proliferation and autophagic flux, which contribute to the gemcitabine resistance.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/metabolismo , Autofagia/efectos de los fármacos , Desoxicitidina/análogos & derivados , Neoplasias Pancreáticas/tratamiento farmacológico , Adulto , Anciano , Apoptosis/efectos de los fármacos , Proteínas Reguladoras de la Apoptosis/genética , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Desoxicitidina/farmacología , Regulación hacia Abajo , Femenino , Humanos , Técnicas In Vitro , Masculino , Persona de Mediana Edad , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Neoplasias Pancreáticas/metabolismo , ARN Interferente Pequeño , Reacción en Cadena en Tiempo Real de la Polimerasa , Gemcitabina
3.
Med Sci Monit ; 21: 3371-9, 2015 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-26537625

RESUMEN

BACKGROUND: The tumor susceptibility gene 101 (TSG101) was originally identified as a tumor-suppressor gene that mediates many molecular and biological processes, such as ubiquitination, endosomal trafficking, cell survival, and virus budding, but its role in hepatocellular carcinoma (HCC) is currently unknown. MATERIAL AND METHODS: We assessed the expression of TSG101 in HCC and paracancerous tissues using qPCR. Then, we used the TSG101-specific siRNA mix to disrupt the expression of TSG101 to investigate the subsequent effect on human hepatoma-7 (Huh7) cells. Western blot was used to detect the protein expression of TSG101 and other molecules. Cell growth assay was performed using CCK8. Transwell assay was used to investigate the migration and invasion ability of Huh7 cells after transfection with of TSG101 siRNA. Flow cytometry was used to estimate the effect of TSG101 knockdown on cell cycle and apoptosis. Confocal laser scanning microscopy was used to observe the actin filaments change and the formation of autophagy. RESULTS: TSG101 was over-expressed in HCC tissues. TSG101 silence was able to suppress Huh7 cell proliferation, migration, and invasion. Furthermore, silencing of TSG101 could induce cell cycle arrest at G1 phase and inhibit the expression of cyclin A and cyclin D, while up-regulating the expression of CDK2. The mechanism might be induction of autophagic cell death and inactivation of Akt and ERK1/2. CONCLUSIONS: TSG101 plays an important role in the development of HCC and may be a target for molecular therapy.


Asunto(s)
Autofagia/genética , Carcinoma Hepatocelular/genética , Puntos de Control del Ciclo Celular/genética , Proteínas de Unión al ADN/genética , Complejos de Clasificación Endosomal Requeridos para el Transporte/genética , Silenciador del Gen , Neoplasias Hepáticas/genética , Factores de Transcripción/genética , Apoptosis , Carcinoma Hepatocelular/terapia , Muerte Celular , Línea Celular Tumoral , Movimiento Celular , Proliferación Celular , Ciclina A/metabolismo , Ciclina D/metabolismo , Proteínas de Unión al ADN/fisiología , Complejos de Clasificación Endosomal Requeridos para el Transporte/fisiología , Citometría de Flujo , Fase G1 , Eliminación de Gen , Humanos , Microscopía Confocal , Microscopía Fluorescente , Invasividad Neoplásica , ARN Interferente Pequeño/metabolismo , Factores de Transcripción/fisiología
4.
Biol Res ; 48: 23, 2015 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-25943891

RESUMEN

BACKGROUND: Hepcidin, encoding by HAMP gene, is the pivotal regulator of iron metabolism, controlling the systemic absorption and transportation of irons from intracellular stores. Abnormal levels of HAMP expression alter plasma iron parameters and lead to iron metabolism disorders. Therefore, it is an important goal to understand the mechanisms controlling HAMP gene expression. RESULTS: Overexpression of Sox2 decrease basal expression of HAMP or induced by IL-6 or BMP-2, whereas, knockdown of Sox2 can increase HAMP expression, furthermore, two potential Sox2-binding sites were identified within the human HAMP promoter. Indeed, luciferase experiments demonstrated that deletion of any Sox2-binding site impaired the negative regulation of Sox2 on HAMP promoter transcriptional activity in basal conditions. ChIP experiments showed that Sox2 could directly bind to these sites. Finally, we verified the role of Sox2 to negatively regulate HAMP expression in human primary hepatocytes. CONCLUSION: We found that Sox2 as a novel factor to bind with HAMP promoter to negatively regulate HAMP expression, which may be further implicated as a therapeutic option for the amelioration of HAMP-overexpression-related diseases, including iron deficiency anemia.


Asunto(s)
Regulación Neoplásica de la Expresión Génica/genética , Hepatocitos/metabolismo , Hepcidinas/genética , Factores de Transcripción SOXB1/genética , Anemia/genética , Anemia/metabolismo , Sitios de Unión , Proteína Morfogenética Ósea 2/metabolismo , Técnicas de Silenciamiento del Gen , Vectores Genéticos , Células Hep G2 , Hepcidinas/metabolismo , Humanos , Interleucina-6/metabolismo , Hierro/metabolismo , Luciferasas , Plásmidos/genética , Regiones Promotoras Genéticas/genética , Factores de Transcripción SOXB1/metabolismo
5.
BMC Gastroenterol ; 14: 62, 2014 Apr 03.
Artículo en Inglés | MEDLINE | ID: mdl-24708487

RESUMEN

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most lethal and prevalent cancers in human population. The 6-fluoro-3-formylchromone (FCC) has been shown to have anti-tumor activity against various tumor cells. However, the effects of FCC on HCC cell lines have not yet been reported. This study aims to research the effects of FCC on HCC and advance the understanding of the molecular mechanism. METHODS: HCC cell line SMMC-7721 was treated with FCC at various concentrations (0, 2, 5, 10, and 20 µg/ml) for 24, 48 and 72 h, respectively. The proliferations of SMMC-7721 cells were measured by MTT assays. After cultured 24 hours, cell cycle distribution and apoptosis were determined by flow cytometry. However, the expression levels of PCNA, Bax and Bcl-2 were measured by western blotting after 48 hours. RESULTS: FCC displayed a dose- and time-dependent inhibition of the SMMC-7721 cell proliferations in vitro. It also induced apoptosis with 45.4% and caused cell accumulation in G0/G1 phase with 21.5%. PCNA and Bcl-2 expression was significantly suppressed by FCC in a dose-dependent manner (P < 0.05), while Bax expression was increased. CONCLUSIONS: FCC could significantly inhibit HCC cell growth in vitro through cell cycle arrest and inducing apoptosis by suppressing PCNA expression and modulating the Bax/Bcl-2 ratio.


Asunto(s)
Apoptosis/efectos de los fármacos , Carcinoma Hepatocelular , Proliferación Celular/efectos de los fármacos , Cromonas/farmacología , Compuestos de Flúor/farmacología , Formiatos/farmacología , Neoplasias Hepáticas , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Antígeno Nuclear de Célula en Proliferación/efectos de los fármacos , Antígeno Nuclear de Célula en Proliferación/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína X Asociada a bcl-2/efectos de los fármacos , Proteína X Asociada a bcl-2/metabolismo
6.
Clin Exp Hypertens ; 36(5): 321-5, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24047449

RESUMEN

OBJECTIVES: This study documented the prevalence and clinical features of white coat hypertension (WCH) among Chinese Han patients with type 2 diabetes mellitus (T2DM). METHODS: Clinic and ambulatory blood pressure (BP) measurements were compared in 856 patients with T2DM to determine the frequency of WCH (WCH was defined as clinical blood pressure ≥140/90 mmHg and daytime blood pressure <135/85 mmHg and/or 24-h ambulatory BP (ABP) mean value of <130/80 mmHg on ambulatory BP monitoring (ABPM). Weight, waist circumference (WC), body mass index (BMI), waist to height ratio (WHtR), fasting blood glucose, glycosylated hemoglobin level and circadian BP patterns were also measured to find clinical features predictive of WCH in T2DM. RESULTS: The prevalence of WCH was 7.36% (63/856) in the overall population, 6.13% (29/473) in male and 8.88% (34/383) in female (p < 0.05). WCH accounted for 14.03% (63/449) of diagnosed hypertension. Age, course of T2DM, male WC were independent protective factors, whereas female sex, smoking and alcohol consumption were independent risk factors for WCH in T2DM. Non-dippers and reverse dippers made up larger proportion of the WCH group (p < 0.01). CONCLUSION: WCH is relatively common among T2DM patients, it is a unique condition distinct from essential hypertension (EH), and WCH patients also exhibit significant differences in clinical parameters.


Asunto(s)
Diabetes Mellitus Tipo 2/epidemiología , Hipertensión de la Bata Blanca/epidemiología , Adulto , Pueblo Asiatico , Determinación de la Presión Sanguínea/métodos , Monitoreo Ambulatorio de la Presión Arterial , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/diagnóstico , Hipertensión Esencial , Femenino , Humanos , Hipertensión/complicaciones , Hipertensión/diagnóstico , Hipertensión/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Hipertensión de la Bata Blanca/complicaciones , Hipertensión de la Bata Blanca/diagnóstico
7.
Hepatogastroenterology ; 60(121): 187-90, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22784943

RESUMEN

BACKGROUND/AIMS: Pancreatic body and tail carcinoma (PBTC) is an aggressive disease with a low resectability rate. Celiac axis infiltration usually contraindicates resection. Extended distal pancreatectomy with combined en bloc celiac axis resection (DP-CAR, also named Appleby operation) was described as a new concept for the curative treatment of these tumors. The aim of this study was to analyze the results of DP-CAR in PBTC. METHODOLOGY: Analyze by summarizing the 24 cases of PBTC during October 2005 to August 2010 in the pancreatic surgery of our hospital and analyzing the clinical manifestations, surgical processing, pathological effects and survival rate of the patients. RESULTS: The postoperative mortality rate was 0%, despite a high morbidity rate (54%). Preoperative intractable abdominal and/or back pain in all the patients was completely alleviated immediately after surgery. During the follow-up survey among all the patients of 2 to 37 months (with an average follow-up survey of 12.67 months), no patient was still alive, with the median survival of 9.25 months. Estimated overall 1- and 3-year survival rates were 46% and 4%, respectively. CONCLUSIONS: DP-CAR offers a high resectability rate without increasing the mortality rate given skilled surgical technique.


Asunto(s)
Arteria Celíaca/cirugía , Pancreatectomía/métodos , Neoplasias Pancreáticas/cirugía , Adulto , Anciano , Femenino , Humanos , Metástasis Linfática , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/mortalidad , Neoplasias Pancreáticas/patología , Tasa de Supervivencia
8.
Forensic Sci Int ; 342: 111505, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36493654

RESUMEN

In order to investigate the sensitivity of parameters and analyze the uncertainty of reconstructed results in traffic accident, the impact of correlations between parameters on accident reconstruction results was taken into account using uncertainty analysis. Based on unscented transformation (UT), a parameter sensitivity analysis method and an efficient uncertainty analysis method in accident reconstruction were proposed. Sensitivity analysis was performed through the sigma point sets generated by the UT method. A first-order response surface model was constructed to analyze the sensitivity of accident reconstruction parameters combined with regression analysis, which is more flexible and controllable than the general experimental design. For the uncertainty analysis of the reconstructed results, the other methods have been used to demonstrate the validity of the proposed method, including the first second-order method of moments (FOSM), the uncertainty theory, and the Monte Carlo (MC) methods, through analyzing the numerical and real-world cases. The results show that the presented method has high accuracy, significantly reduces the computational burden, and does not depend on the distribution type of variables. When considering the effect of the correlation between parameters of the vehicle-pedestrian crash on accident reconstruction results, the results show that the correlation coefficient between random variables had a much more significant impact on the standard deviation of vehicle speed than on the mean value of vehicle speed. Regardless of negative or positive correlations, the relative error of standard deviation of vehicle speed increased continuously as the correlation increased, reaching 52%. The proposed method is effective and reliable for vehicle collision accident reconstruction under uncertainty and correlation, which can provide more comprehensive information in accident reconstruction.


Asunto(s)
Peatones , Humanos , Incertidumbre , Accidentes de Tránsito , Método de Montecarlo
9.
Spectrochim Acta A Mol Biomol Spectrosc ; 303: 123178, 2023 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-37499473

RESUMEN

Abiotic stress and oxidative stress are closely related to the health status of plants. Plants will produce oxidative stress under abiotic stress, induce mitochondrial dysfunction, cause programmed cell death, and decrease plant survival rate. It is well known that rice is an essential crop for humans, but its cadmium tolerance is poor. Therefore, it is crucial to determine whether cadmium stress causes oxidative stress in rice in order to guide rice cultivation. Hydrogen peroxide (H2O2), a highly reactive oxygen species (ROS), is one of the most critical signals in corps under oxidative stress. In this work, we adopted a near-infrared (NIR) H2O2 fluorescent probe YFE-1 and a cadmium ion (Cd2+) fluorescent probe SCP to observe the fluctuation of H2O2 in rice roots under Cd2+ co-incubation conditions. Due to the advantages of fast response (within 2 min), a large Stokes shift (181 nm), good selectivity, and a low detection limit (LOD:26.4 nM), YFE-1 achieved the visualization of H2O2 produced by Cd2+ stress in rice roots. This study provides a new idea for assessing the risk of oxidative stress of Cd2+ in rice roots. It is expected to guide the control of Cd2+ in the rice planting industry to improve rice yield.


Asunto(s)
Cadmio , Oryza , Humanos , Cadmio/metabolismo , Peróxido de Hidrógeno/metabolismo , Oryza/metabolismo , Colorantes Fluorescentes/metabolismo , Fluorescencia , Estrés Oxidativo , Antioxidantes/metabolismo , Plantas/metabolismo , Raíces de Plantas/metabolismo
10.
Tissue Eng Regen Med ; 20(3): 447-459, 2023 06.
Artículo en Inglés | MEDLINE | ID: mdl-36947320

RESUMEN

BACKGROUND: Human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising therapy for immune and inflammatory diseases. However, how to maintain the activity and unique properties during cold storage and transportation is one of the key factors affecting the therapeutic efficiency of hUCMSCs. Schisandrin B (SchB) has many functions in cell protection as a natural medicine. In this study, we investigated the protective effects of SchB on the hypothermic preservation of hUCMSCs. METHODS: hUCMSCs were isolated from Wharton's jelly. Subsequently, hUCMSCs were exposed to cold storage (4 °C) and 24-h re-warming. After that, cells viability, surface markers, immunomodulatory effects, reactive oxygen species (ROS), mitochondrial integrity, apoptosis-related and antioxidant proteins expression level were evaluated. RESULTS: SchB significantly alleviated the cells injury and maintained unique properties such as differentiation potential, level of surface markers and immunomodulatory effects of hUCMSCs. The protective effects of SchB on hUCMSCs after hypothermic storage seemed associated with its inhibition of apoptosis and the anti-oxidative stress effect mediated by nuclear factor erythroid 2-related factor 2 signaling. CONCLUSION: These results demonstrate SchB could be used as an agent for hypothermic preservation of hUCMSCs.


Asunto(s)
Lignanos , Células Madre Mesenquimatosas , Humanos , Células Madre Mesenquimatosas/metabolismo , Lignanos/farmacología , Lignanos/metabolismo , Cordón Umbilical
11.
Cancer Sci ; 103(10): 1756-63, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22716017

RESUMEN

Cancer cells can metastasize throughout the body by various mechanisms, including the lymphatic system, resulting in tumor-induced lymphangiogenesis that can profoundly affect patient survival. The aim of the present study was to examine the role of lymphangiogenesis in the metastasis of pancreatic cancer to the peripheral nerve plexus. Immunohistochemistry was performed to analyze specimens obtained from 70 ductal adenocarcinoma patients. The markers used included lymphangiogenic factor vascular endothelial growth factor (VEGF)-C, the lymphatic-specific marker D2-40, and cytokeratin 19, an independent prognostic factor for pancreatic tumors. The relationship between survival rate and invasion of both the lymphatic vessels and peripancreatic nerve plexus (PNP) was evaluated, with clearly elevated lymphatic vessel density (LVD) in tissues adjacent to the cancer tissues. In fact, LVD levels were higher in adjacent tissues than in localized cancer tissues, and lymphatic vessel invasion into tissues adjacent to the tumor was significantly correlated with both PNP invasion (P = 0.005) and lymph node metastasis (P = 0.010). Correspondingly, LVD in tissues adjacent to the tumor was correlated with both invasion of lymphatic vessels surrounding the tumor (P = 0.024) and VEGF-C expression (P = 0.031); in addition, VEGF-C expression was correlated with invasion of lymphatic vessels around the tumor (P = 0.004). Survival rates were significantly lower in patients in whom there was peritumor lymphatic vessel invasion (P < 0.001), extrapancreatic nerve plexus invasion (P = 0.001), and/or lymph node metastasis (P < 0.001). Based on these results, lymphatic invasion associated with adjacent tumor growth likely contributes to the development of metastatic tumors that invade the PNP.


Asunto(s)
Carcinoma Ductal Pancreático/patología , Linfangiogénesis/fisiología , Metástasis Linfática/patología , Neoplasias Pancreáticas/patología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Ductal Pancreático/metabolismo , Carcinoma Ductal Pancreático/mortalidad , Femenino , Humanos , Inmunohistoquímica , Vasos Linfáticos/patología , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias Pancreáticas/metabolismo , Neoplasias Pancreáticas/mortalidad , Factor C de Crecimiento Endotelial Vascular/análisis , Factor C de Crecimiento Endotelial Vascular/biosíntesis
12.
J Biomed Sci ; 19: 15, 2012 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-22305266

RESUMEN

BACKGROUND: Studies have shown the existence of p21 induction in a p53-dependent and -independent pathway. Our previous study indicates that DOX-induced p65 is able to bind the p21 promoter to activate its transactivation in the cells. METHODS: Over-expression and knock-down experiments were performed in Human Pancreatic Carcinoma (PANC1) cells. Cell cycle and cell death related proteins were assessed by Western Blotting. Cytotoxicity assay was checked by CCK-8 kit. Cell growth was analyzed by flow cytometers. RESULTS: Here we showed that over-expression of p65 decreased the cytotoxic effect of DOX on PANC1 cells, correlating with increased induction of cytoplasmic p21. We observed that pro-caspase-3 physically associated with cytoplasmic p21, which may be contribution to prevent p21 translocation into the nucleus. Our data also suggested that no clear elevation of nuclear p21 by p65 provides a survival advantage by progression cell cycle after treatment of DOX. Likewise, down-regulation of p65 expression enhanced the cytotoxic effect of DOX, due to a significant decrease of mRNA levels of anti-apoptotic genes, such as the cellular inhibitor of apoptosis-1 (c-IAP1), and the long isoform of B cell leukemia/lymphoma-2 (Bcl-2), leading to efficient induction of caspase-3 cleavage in the cells. More, we present evidence that over-expression of p53 or p53/p65 in the PANC1 cells were more sensitive to DOX treatment, correlated with activation of caspase-3 and clear elevation of nuclear p21 level. Our previous data suggested that expression of p21 increases Gefitinib-induced cell death by blocking the cell cycle at the G1 and G2 phases. The present findings here reinforced this idea by showing p21's ability of potentiality of DOX-induced cell death correlated with its inhibition of cell cycle progression after over-expression of p53 or p53/p65. CONCLUSION: Our data suggested p65 could increase p53-mediated cell death in response to DOX in PANC1 cells. Thus, it is worth noting that in p53 null or defective tumors, targeting in down-regulation of p65 may well be useful, leading to the potentiality of chemotherapeutic drugs.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/biosíntesis , Doxorrubicina/toxicidad , Factor de Transcripción ReIA/metabolismo , Western Blotting , Muerte Celular , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Humanos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Proteína p53 Supresora de Tumor/metabolismo
13.
Appl Physiol Nutr Metab ; 47(9): 949-962, 2022 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-35728265

RESUMEN

This study examined the alterations of heart rate variability (HRV) following iso-duration resistance (RES) and sprint-interval exercises (SIE) by comparing with that of non-exercise control (CON) in 14 non-obese (NOB) and 15 obese (OB) young men. Time and frequency domain measures as well as nonlinear metrics of HRV were assessed before and immediately after exercise, and during every 20 min until 120 min post-exercise. The variables during the first 4 h of actual sleep time at night, and the period of 12-14 h post-exercise were also measured. All trials were scheduled at 20:00. It was found that RES and SIE attenuated the HRV in both NOB and OB (P < 0.05), and the attenuated HRV restored progressively during subsequent recovery. Although the changes in HRV indices among various time points during the recovery period and its interaction across RES, SIE, and CON were not different between NOB and OB, the restoration of the declined HRV indices to corresponding CON level in the 2 exercise trials in OB appeared to be sluggish in relative to NOB. Notwithstanding, post-exercise HRV that recorded during actual sleep at night and during 12-14 h apart from exercise were unvaried among the 3 trials in both groups (P > 0.05). These findings suggest that obesity is likely to be a factor hindering the removal of exercise-induced cardiac autonomic disturbance in young men. Nonetheless, the declined HRV following both the RES and SIE protocols was well restored after a resting period of ∼10 h regardless of obesity. The study was registered at ISRCTN as https://doi.org/10.1186/ISRCTN88544091.


Asunto(s)
Sistema Nervioso Autónomo , Ejercicio Físico , Sistema Nervioso Autónomo/fisiología , Ejercicio Físico/fisiología , Corazón/fisiología , Frecuencia Cardíaca/fisiología , Humanos , Masculino , Obesidad/terapia
14.
Front Oncol ; 12: 1030080, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36591477

RESUMEN

Introduction: Central pancreatectomy (CP) is a standard surgical procedure for benign and low-grade malignant pancreatic neoplasms in the body and neck of the pancreas. Higher incidence of clinically relevant postoperative pancreatic fistula (CR-POPF) after CP than after pancreaticoduodenectomy (PD) or distal pancreatectomy (DP) has been reported, but no nomogram for prediction of CR-POPF after open CP has been previously established. Methods: Patients undergoing open CP for benign or low-grade malignant pancreatic neoplasms in the department of Hepatobiliary and Pancreatic (HBP) surgery of Shanghai Changhai Hospital affiliated to Naval Medical University between January 01, 2009 and December 31,2020 were enrolled. Pre-, intra- and post-operative parameters were analyzed retrospectively. Results: A total of 194 patients, including 60 men and 134 women, were enrolled with median age of 52 years (21~85 years). 84 patients (43.3%) were overweight (BMI>23.0 Kg/m2) and 14 (7.2%) were obese (BMI>28.0 Kg/m2). Pathological diagnoses ranged from serous cystic neoplasm (32.5%), solid pseudopapillary neoplasm (22.2%), pancreatic neuroendocrine tumor (20.1%), intraductal papillary mucinous neoplasm (18.0%) to mucinous cystic neoplasm (5.2%). All patients had soft pancreatic texture. Main pancreatic duct diameters were ≤0.3cm for 158 patients (81.4%) and were ≥0.5cm in only 12 patients (6.2%). A stapler (57.7%) or hand-sewn closure (42.3%) were used to close the pancreatic remnant. The pancreatic anastomosis techniques used were duct to mucosa pancreaticojejunostomy (PJ)-interrupted suture (47.4%), duct to mucosa PJ-continuous suture (43.3%), duct to mucosa "HO" half-purse binding PJ (5.2%) and invaginating pancreaticogastrostomy (4.1%). Post-surgical incidences of CR-POPF of 45.9%, surgical site infection of 28.9%, postpancreatectomy hemorrhage of 7.7% and delayed gastric emptying of 2.1% were found. Obesity and pancreatic anastomosis technique were independent risk factors of CR-POPF, with a concordance index of 0.675 and an Area Under the Curve of 0.678. Discussion: This novel nomogram constructed according to obesity and pancreatic anastomosis technique showed moderate predictive performance of CR-POPF after open CP.

15.
Biochem Biophys Res Commun ; 406(4): 552-7, 2011 Mar 25.
Artículo en Inglés | MEDLINE | ID: mdl-21352803

RESUMEN

MicroRNAs (miRNAs) have emerged as important regulators in the development of pancreatic cancer and may be a valuable therapeutic application. DPC4/Smad4 is a critical tumor suppressor involved in the progression of pancreatic cancer, but few studies have been conducted to determine its relationship with miRNAs. In this study, we identify miR-421 as a potential regulator of DPC4/Smad4. We find that in human clinical specimens of pancreatic cancer miR-421 is aberrantly upregulated while DPC4/Smad4 is strongly repressed, and their levels of expression are inversely correlated. Moreover, ectopic expression of miR-421 significantly decreases DPC4/Smad4 protein level in pancreatic cancer cell lines and simultaneously promotes cell proliferation and colony formation in vitro. Our findings identify miR-421 as a potent regulator of DPC4/Smad4, which may provide a novel therapeutic strategy for treatment of DPC4/Smad4-driven pancreatic cancer.


Asunto(s)
Regulación Neoplásica de la Expresión Génica , MicroARNs/metabolismo , Neoplasias Pancreáticas/genética , Proteína Smad4/genética , Proliferación Celular , Humanos , MicroARNs/genética , Neoplasias Pancreáticas/patología
16.
Chin Clin Oncol ; 9(4): 54, 2020 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-32576018

RESUMEN

BACKGROUND: Radical antegrade modular pancreatosplenectomy (RAMPS) has been adopted by some surgeons in the treatment of left-sided pancreatic cancer (PDAC). Low disease incidence and heterogenous disease biology make robust prospective comparison of RAMPS and standard distal pancreatosplenectomy (DPS) difficult. METHODS: Consecutive cases of chemo-naïve patients undergoing open RAMPS and DPS for PDAC between 2010-2017 at two international high-volume pancreatectomy centers were compared. Cox proportional hazard modeling was utilized for multivariate analysis. RESULTS: We identified 193 DPS and 253 RAMPS during the study period. DPS was associated with higher rates of median estimated blood loss (500 vs. 300 cc, P<0.001), median total harvested lymph nodes (18 vs. 12, P<0.001) and R0 resection (94.3% vs. 88.9%, P=0.013). There were no differences in rates of postoperative pancreatic fistula (16.5% vs. 17.8%, P=1) or postoperative hemorrhage (5.9% vs. 3.6%, P=0.385) (DPS vs. RAMPS). After controlling for significant clinical pathological parameters, RAMPS was associated with non-superior recurrence-free survival (RFS) (HR 0.29; 95% CI, 0.07-1.27, P=0.101) and overall-survival (HR 1.03; 95% CI, 0.71-1.49, P=0.895) compared with DPS. Similar results were observed in node-positive patients. CONCLUSIONS: RAMPS is safe and effective in the treatment of PDAC, but is not associated with an improvement in either RFS or overall-survival over DPS.


Asunto(s)
Pancreatectomía/métodos , Neoplasias Pancreáticas/cirugía , Esplenectomía/métodos , Anciano , Femenino , Humanos , Masculino , Neoplasias Pancreáticas
18.
Rev Biol Trop ; 57(1-2): 79-88, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19637690

RESUMEN

Age and growth parameters were estimated for bigeye tuna Thunnus obesus Lowe, 1839 sampled from China longline fisheries in the central Atlantic Ocean from October 2002 to July 2003 and from August 2004 to March 2005. The von Bertalanffy growth parameters were estimated at L(infinity)=217.9 cm fork length, k=0.23 year(-1), and t(0)=-0.44 year. The total mortality rate (Z) was estimated to be from 0.82 to 1.02, the fishing mortality (F) and the natural mortality were 0.54 year(-1) and 0.39 year(-1), respectively. The exploitation ratio (E) was 0.35. This study provides the detailed estimates of growth and mortality rate for bigeye tuna in the central Atlantic Ocean, which can be used as biological input parameters in further stock evaluations in this region. However, age analysis, additional validation of the size composition and stock structure are needed for future studies.


Asunto(s)
Mortalidad , Atún/crecimiento & desarrollo , Animales , Océano Atlántico , China , Femenino , Masculino , Atún/clasificación
19.
Zhonghua Yi Xue Za Zhi ; 87(43): 3060-3, 2007 Nov 20.
Artículo en Zh | MEDLINE | ID: mdl-18261352

RESUMEN

OBJECTIVE: To discuss a rare variation of abdominal aorta breaking in two. METHODS: An in-patients, female, aged 76, admitted for asthenia of right extremities, underwent gadolinium-enhanced magnetic resonance angiography (MRA) of cerebral and abdominal vessels and abdominal MRI in whom the conventional angiography had failed to reveal this vascular abnormality. RESULTS: MRA showed a clearly separated abdominal aorta. The upper part of the abdominal aorta terminated under the two renal artery branches and the lower part terminated at the level of L(3 - 4). The compensated enlarged superior and inferior mesenteric artery connected these two isolated parts of abdominal aorta. CONCLUSION: This rare variation of abdominal aorta without any symptom is probably caused by some external force during the embryonic period.


Asunto(s)
Aorta Abdominal/anomalías , Enfermedades de la Aorta/diagnóstico , Angiografía por Resonancia Magnética , Anciano , Enfermedades de la Aorta/congénito , Femenino , Humanos , Arterias Mesentéricas/anomalías , Arteria Renal/anomalías
20.
PLoS One ; 10(3): e0120694, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25815885

RESUMEN

During chemotherapy, drug resistance caused by autophagy remains a major challenge to successful treatment of cancer patients. The purpose of this study is to show that ulinastatin (UTI), a trypsin inhibitor, could reduce the resistance of liver cancer cells to chemotherapeutic agent epirubicin (EPI). We achieved this conclusion by analyzing the effect of EPI alone or UTI plus EPI on SMMC-7721 and MHCC-LM3 liver cancer cells. We also generated an EPI-resistant liver cancer cell line (MHCC-LM3er cells), and found that UTI could sensitize the LM3er cells to EPI. Autophagy usually functions to protect cancer cells during chemotherapy. Our study showed that UTI inhibited the autophagy induced by EPI in liver cancer cells, which promoted apoptosis, and therefore, reduced the resistance of the cancer cells to EPI. Further studies showed that the UTI-mediated inhibition on autophagy was achieved by inhibiting transcriptional factor nuclear factor-κB (NF-κB) signaling pathway. To verify our results in vivo, we injected MHCC-LM3 liver cancer cells or EPI-resistant LM3er cells into mice, and found that EPI could only effectively inhibit the growth of tumor in MHCC-LM3 cell-injected mice, but not in LM3er cell-injected mice. However, when UTI was also administered, the growth of tumor was inhibited in the MHCC-LM3er cell-injected mice as well. Our results suggest that UTI may be used in combination with anti-cancer drugs, such as EPI, to improve the outcome of cancer therapy.


Asunto(s)
Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Carcinoma Hepatocelular/tratamiento farmacológico , Resistencia a Antineoplásicos/efectos de los fármacos , Epirrubicina/farmacología , Glicoproteínas/farmacología , Neoplasias Hepáticas/tratamiento farmacológico , Animales , Antibióticos Antineoplásicos/farmacología , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Western Blotting , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Humanos , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Masculino , Ratones , Ratones Desnudos , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Inhibidores de Tripsina/farmacología , Células Tumorales Cultivadas , Ensayos Antitumor por Modelo de Xenoinjerto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA